Navigation Links
Life Technologies to Provide Ion Torrent Sequencing Platform to Quest Diagnostics for Development of New Molecular Tests
Date:1/9/2014

CARLSBAD, Calif., Jan. 9, 2014 /PRNewswire/ -- Life Technologies (NASDAQ: LIFE) has completed a multi-year license and supply agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, that gives Quest rights to develop molecular tests on the Ion Torrent™ next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their business. 

DNA sequencing is a process that determines the order of individual nucleotides of DNA molecules across a single gene, several genes or a full genome. Unlike older technologies, next-generation sequencing (NGS) platforms can sequence multiple molecules simultaneously, providing greater information about the genetic basis of disease for lower cost. Ion Torrent™ technology combines speed and reliability with the ability to analyze large, multi-gene DNA or RNA panels from extremely small samples, such as those obtained from needle aspirates, circulating nucleic acids and circulating tumor cells.

"Next-generation sequencing is a highly advanced technology with great potential to improve clinical care, research and cost savings across several fields of medicine," said Jay Wohlgemuth, M.D., Senior Vice President, Science and Innovation, Quest Diagnostics. "Quest is actively developing NGS-based tests and working with top providers, such as Life Technologies, to expand our capabilities in this exciting new field. With this agreement, we can build on our successes in NGS to accelerate the future clinical benefit and positive impact of this technology for patients and providers across several disease areas, including cancer, neurology and women'
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ISTO Technologies Appoints James McGorry to Board of Directors
2. Patient Safety Technologies, Inc. Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $2.22 Per Common Share in Cash
3. BioSpecifics Technologies Corp. Announces Top-line Data from Phase 2 Trial of CCH for Canine Lipoma
4. Global Algae Biofuel Technologies Market 2014-2018 with a CAGR of 43.4 Percent for the Period 2013–2018
5. IROA Technologies automates metabolic profiling with launch of labeling and software kits
6. Smart Imaging Technologies and InvitroCue Team Up to Bring Digital Pathology to Asia
7. New venue, new conference, new courses, new technologies for Electronic Imaging 2014
8. Ancon Technologies New Cancer Screening Technology Will Help Defeat Cancer
9. United Technologies plans $10 million investment for UConn systems engineering institute
10. Adaptive Biotechnologies and Collaborators Present 16 Studies Demonstrating Clinical Significance of ImmunoSequencing at 55th Annual Meeting of the American Society for Hematology
11. Great Lakes NeuroTechnologies Awarded Patent For Sensor Based Continuous Parkinsons Assessment During Daily Activities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 2013 was a banner year ... Technologies®. They saw continued independent research led by the ... awarded a $1 million grant from the Susanne Marcus ... Behavior” a peer reviewed journal, Amy Grant highlighted Brainwave ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... January 14, 2014 Histogen, Inc., a ... of cells grown under simulated embryonic conditions, today announced ... with Suneva Medical, Inc. for physician-dispensed aesthetic products containing ... , This agreement is an amendment to the existing ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... elected mayor of Colorados largest city, businessman John Hickenlooper invited ... was to ceremoniously bury the hatchet of intra-regional rivalry and ... metropolitan area, or not at all. , ,Every suburban ... a near-unanimous effort to pass a $4.7-billion mass transit initiative ...
... data quality firm Firstlogic for about $69 million ... second quarter. , ,Firstlogic is a privately held firm that ... sure their data is as correct as they need to ... call centers, web sites, customer relationship management systems, and business ...
... settled with a Belgian company that sued last September ... virus genotyping technology from Innogenetics, for undisclosed financial terms. ... Aril 2004 Third Wave forged a deal under which ... line of products in Europe. It was Third Wave's ...
Cached Biology Technology:Economic collaboration in Denver sets tall goal for Wisconsin 2Economic collaboration in Denver sets tall goal for Wisconsin 3
(Date:4/23/2014)... using triclosan as an antimicrobial ingredient in soaps, toothpastes ... are reporting new evidence that appears to support these ... Chemical Research in Toxicology , found that triclosan, as ... growth of human breast cancer cells in lab dishes ... and colleagues note that hormonal imbalances seem to play ...
(Date:4/23/2014)... of the family of bacteria that causes whooping ... reveals surprising findings about the bacteria,s origin and ... strategies to control this respiratory disease, which kills ... of 343 strains of the Bordetella pertussis ... the last 100 years illustrates how vaccination has ...
(Date:4/23/2014)... HOUSTON, April 23, 2014 A biomedical engineer at ... highly innovative technology to make blood transfusions safer. His ... the National Institutes of Health (NIH). , Blood ... one of modern medicine,s absolute necessities. Without them, for ... mean transfusions are perfect, however. There,s strong evidence that ...
Breaking Biology News(10 mins):In lab tests, the antimicrobial ingredient triclosan spurs growth of breast cancer cells 2Impact of whooping cough vaccination revealed 2UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3
... a single dose of chemotherapy alongside radiotherapy could improve ... long-term side-effects, a new study reports.,As many as 96% ... ten years from diagnosis (1), but more advanced forms ... can have serious long-term complications.,Researchers at The Institute of ...
... terrorists targeted the United States with an anthrax attack, health ... such as knowing the likelihood of an individual becoming infected, ... how long to give antibiotics to protect people from ... letters killed five people and infected 17 others in the ...
... and herbs, especially Mexican oregano, all contain apigenin and ... the lab by inhibiting an important enzyme, according to ... induced cell death in two aggressive human pancreatic cancer ... we pre-treated cancer cells with apigenin for 24 hours, ...
Cached Biology News:Chemotherapy before radiotherapy for testicular cancer could reduce long-term side-effects 2Answering crucial questions about anthrax exposure 2Answering crucial questions about anthrax exposure 3Answering crucial questions about anthrax exposure 4Celery, artichokes contain flavonoids that kill human pancreatic cancer cells 2
RABBIT ANTI ISOCITRATE DEHYDROGENASE...
... two highly efficient methods of identifying recombinant ... By using the large-scale screen method in ... is to transfer partial colonies of E. ... into the solutions provided by the kits ...
Recombinant Rat Leptin, CF...
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
Biology Products: